{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T07:56:59Z","timestamp":1775289419955,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-024-01567-1","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T03:37:59Z","timestamp":1733369879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The melanocortin receptor genes are linked to and associated with the risk of polycystic ovary syndrome in Italian families"],"prefix":"10.1186","volume":"17","author":[{"given":"Rongling","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Gragnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"issue":"4","key":"1567_CR1","first-page":"305","volume":"50","author":"R Hart","year":"2008","unstructured":"Hart R. PCOS and infertility. Panminerva Med. 2008;50(4):305\u201314.","journal-title":"Panminerva Med"},{"issue":"1","key":"1567_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2337\/diacare.22.1.141","volume":"22","author":"DA Ehrmann","year":"1999","unstructured":"Ehrmann DA, et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999;22(1):141\u20136.","journal-title":"Diabetes Care"},{"issue":"3","key":"1567_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.fertnstert.2018.11.034","volume":"111","author":"LB Marchesan","year":"2019","unstructured":"Marchesan LB, Spritzer PM. ACC\/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome. Fertil Steril. 2019;111(3):579\u2013e5871.","journal-title":"Fertil Steril"},{"key":"1567_CR4","doi-asserted-by":"crossref","unstructured":"Kolhe JV et al. PCOS and Depression: Common Links and Potential Targets. Reprod Sci, 2021.","DOI":"10.1007\/s43032-021-00765-2"},{"issue":"11","key":"1567_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11920-017-0834-2","volume":"19","author":"LG Cooney","year":"2017","unstructured":"Cooney LG, Dokras A. Depression and anxiety in polycystic ovary syndrome: etiology and treatment. Curr Psychiatry Rep. 2017;19(11):83.","journal-title":"Curr Psychiatry Rep"},{"issue":"12","key":"1567_CR6","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1080\/09513590.2016.1196177","volume":"32","author":"G Franik","year":"2016","unstructured":"Franik G, et al. Sleep disturbances in women with polycystic ovary syndrome. Gynecol Endocrinol. 2016;32(12):1014\u20137.","journal-title":"Gynecol Endocrinol"},{"key":"1567_CR7","doi-asserted-by":"publisher","first-page":"p9240569","DOI":"10.1155\/2022\/9240569","volume":"2022","author":"Y Xu","year":"2022","unstructured":"Xu Y, Qiao J. Association of Insulin Resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature. J Healthc Eng. 2022;2022:p9240569.","journal-title":"J Healthc Eng"},{"issue":"1","key":"1567_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psyneuen.2004.05.007","volume":"30","author":"R Rosmond","year":"2005","unstructured":"Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology. 2005;30(1):1\u201310.","journal-title":"Psychoneuroendocrinology"},{"key":"1567_CR9","doi-asserted-by":"crossref","unstructured":"Camili FE et al. Oncostatin M is related to polycystic ovary syndrome-case control study. Biomedicines, 2024. 12(2).","DOI":"10.3390\/biomedicines12020355"},{"issue":"2","key":"1567_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/cphy.c150015","volume":"6","author":"JP Herman","year":"2016","unstructured":"Herman JP, et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol. 2016;6(2):603\u201321.","journal-title":"Compr Physiol"},{"key":"1567_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1196\/annals.1367.006","volume":"1083","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E, Economou F. Stress in women: metabolic syndrome and polycystic ovary syndrome. Ann N Y Acad Sci. 2006;1083:54\u201362.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"1567_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.steroids.2011.12.003","volume":"77","author":"F Gonzalez","year":"2012","unstructured":"Gonzalez F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77(4):300\u20135.","journal-title":"Steroids"},{"issue":"5\u20136","key":"1567_CR13","first-page":"300","volume":"62","author":"A Tokmak","year":"2017","unstructured":"Tokmak A, et al. Effect of obesity on clinical parameters and pregnancy rates in women with polycystic ovary syndrome undergoing ovulation induction cycles. J Reprod Med. 2017;62(5\u20136):300\u20134.","journal-title":"J Reprod Med"},{"issue":"1","key":"1567_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12958-022-00967-6","volume":"20","author":"G Guney","year":"2022","unstructured":"Guney G, et al. The role of ERK-1 and ERK-2 gene polymorphisms in PCOS pathogenesis. Reprod Biol Endocrinol. 2022;20(1):95.","journal-title":"Reprod Biol Endocrinol"},{"issue":"17","key":"1567_CR15","doi-asserted-by":"publisher","first-page":"9819","DOI":"10.3390\/ijms23179819","volume":"23","author":"M Amin","year":"2022","unstructured":"Amin M, et al. Comorbidity of Novel CRHR2 gene variants in type 2 diabetes and depression. Int J Mol Sci. 2022;23(17):9819.","journal-title":"Int J Mol Sci"},{"key":"1567_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/TACG.S39993","volume":"7","author":"C Gragnoli","year":"2014","unstructured":"Gragnoli C. Hypothesis of the neuroendocrine cortisol pathway gene role in the comorbidity of depression, type 2 diabetes, and metabolic syndrome. Appl Clin Genet. 2014;7:43\u201353.","journal-title":"Appl Clin Genet"},{"key":"1567_CR17","doi-asserted-by":"crossref","unstructured":"Amin M et al. Implication of Melanocortin Receptor Genes in the familial comorbidity of type 2 diabetes and depression. Int J Mol Sci, 2022;23(15).","DOI":"10.3390\/ijms23158350"},{"key":"1567_CR18","doi-asserted-by":"crossref","unstructured":"Amin M et al. Familial linkage and association of the NR3C1 gene with type 2 diabetes and Depression Comorbidity. Int J Mol Sci, 2022;23(19).","DOI":"10.3390\/ijms231911951"},{"key":"1567_CR19","doi-asserted-by":"crossref","unstructured":"Amin M et al. Novel linkage and association of the mineralocorticoid receptor gene (NR3C2) with familial type 2 diabetes and depression and their comorbidity. Aspects Mol Med, 2023;1.","DOI":"10.1016\/j.amolm.2023.100003"},{"issue":"3","key":"1567_CR20","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbadis.2013.05.004","volume":"1842","author":"C Girardet","year":"2014","unstructured":"Girardet C, Butler AA. Neural melanocortin receptors in obesity and related metabolic disorders. Biochim Biophys Acta. 2014;1842(3):482\u2013482.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"1567_CR21","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1210\/jc.2018-00258","volume":"103","author":"KL Ayers","year":"2018","unstructured":"Ayers KL, et al. Melanocortin 4 receptor pathway dysfunction in obesity: patient stratification aimed at MC4R agonist treatment. J Clin Endocrinol Metab. 2018;103(7):2601\u201312.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1567_CR22","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1210\/en.2010-0716","volume":"152","author":"D Srisai","year":"2011","unstructured":"Srisai D, et al. Characterization of the Hyperphagic response to Dietary Fat in the MC4R knockout mouse. Endocrinology. 2011;152(3):890\u2013890.","journal-title":"Endocrinology"},{"key":"1567_CR23","doi-asserted-by":"crossref","unstructured":"Ji LQ, Hong Y, Tao YX. Melanocortin-5 receptor: Pharmacology and its regulation of Energy Metabolism. Int J Mol Sci, 2022;23(15).","DOI":"10.3390\/ijms23158727"},{"key":"1567_CR24","doi-asserted-by":"crossref","unstructured":"Novoselova TV, Chan LF, Clark AJL. Pathophysiology of melanocortin receptors and their accessory proteins. Best practice & research. Clinical endocrinology & metabolism; 2018;32(2)93\u2013106.","DOI":"10.1016\/j.beem.2018.02.002"},{"issue":"6","key":"1567_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1600-0781.2004.00132.x","volume":"20","author":"E Healy","year":"2004","unstructured":"Healy E. Melanocortin 1 receptor variants, pigmentation, and skin cancer susceptibility. Photodermatol Photoimmunol Photomed. 2004;20(6):283\u20138.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"1567_CR26","doi-asserted-by":"crossref","unstructured":"Mun Y, Kim W, Shin D. Melanocortin 1 receptor (MC1R): pharmacological and therapeutic aspects. Int J Mol Sci, 2023;24(15).","DOI":"10.3390\/ijms241512152"},{"issue":"2\u20134","key":"1567_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000351719","volume":"75","author":"GS Gerhard","year":"2013","unstructured":"Gerhard GS, et al. Next-generation sequence analysis of genes associated with obesity and nonalcoholic fatty liver disease-related cirrhosis in extreme obesity. Human Hered. 2013;75(2\u20134):144\u201351.","journal-title":"Human Hered"},{"key":"1567_CR28","doi-asserted-by":"publisher","first-page":"e1070","DOI":"10.31661\/gmj.v7i0.1070","volume":"7","author":"MH Nooranizadeh","year":"2018","unstructured":"Nooranizadeh MH, et al. Enhancement of Melanocortin-4 receptor (MC4R) and constancy of Kiss1 mRNAs expression in the Hypothalamic Arcuate Nucleus in a model of polycystic ovary syndrome rat. Galen Med J. 2018;7:e1070.","journal-title":"Galen Med J"},{"issue":"8","key":"1567_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/09513590.2019.1576614","volume":"35","author":"S Hepsen","year":"2019","unstructured":"Hepsen S, et al. Melanocortin 3 receptor gene polymorphism is associated with polycystic ovary syndrome in Turkish population. Gynecol Endocrinol. 2019;35(8):685\u201390.","journal-title":"Gynecol Endocrinol"},{"key":"1567_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12958-015-0050-z","volume":"13","author":"H Yuan","year":"2015","unstructured":"Yuan H, et al. Interaction between common variants of FTO and MC4R is associated with risk of PCOS. Reprod Biol Endocrinol. 2015;13:55.","journal-title":"Reprod Biol Endocrinol"},{"key":"1567_CR31","doi-asserted-by":"publisher","first-page":"144372","DOI":"10.1016\/j.gene.2020.144372","volume":"733","author":"K Yu","year":"2020","unstructured":"Yu K, et al. Association between MC4R rs17782313 genotype and obesity: a meta-analysis. Gene. 2020;733:144372.","journal-title":"Gene"},{"issue":"6","key":"1567_CR32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1055\/s-0032-1328878","volume":"30","author":"RS Legro","year":"2012","unstructured":"Legro RS. Obesity and PCOS: implications for diagnosis and treatment. Semin Reprod Med. 2012;30(6):496\u2013506.","journal-title":"Semin Reprod Med"},{"issue":"1","key":"1567_CR33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12881-020-01100-3","volume":"21","author":"JW Sull","year":"2020","unstructured":"Sull JW, Kim G, Jee SH. Association of MC4R (rs17782313) with diabetes and cardiovascular disease in Korean men and women. BMC Med Genet. 2020;21(1):160.","journal-title":"BMC Med Genet"},{"issue":"5","key":"1567_CR34","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.fertnstert.2004.07.924","volume":"82","author":"MB Roldan Martin","year":"2004","unstructured":"Roldan Martin MB, et al. Mutational analysis of the melanocortin-4 receptor (MC4R) gene in children with premature pubarche and adolescent girls with hyperandrogenism. Fertil Steril. 2004;82(5):1460\u20132.","journal-title":"Fertil Steril"},{"key":"1567_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","volume":"182","author":"S Patel","year":"2018","unstructured":"Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27\u201336.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"1567_CR36","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.2337\/db14-1257","volume":"64","author":"DA Morgan","year":"2015","unstructured":"Morgan DA, et al. Regulation of glucose tolerance and sympathetic activity by MC4R signaling in the lateral hypothalamus. Diabetes. 2015;64(6):1976\u201387.","journal-title":"Diabetes"},{"key":"1567_CR37","doi-asserted-by":"crossref","unstructured":"Metzger PJ et al. A human obesity-associated MC4R mutation with defective Gq\/11\u03b1 signaling leads to hyperphagia in mice. J Clin Invest, 2024;134(4).","DOI":"10.1172\/JCI165418"},{"issue":"1","key":"1567_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"EA Rotterdam","year":"2004","unstructured":"Rotterdam EA. .-S.P.c.w.g., revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137.","journal-title":"Hum Reprod"},{"issue":"3","key":"1567_CR39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559\u201375.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1567_CR40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000329467","volume":"71","author":"T Hiekkalinna","year":"2011","unstructured":"Hiekkalinna T, et al. PSEUDOMARKER: a powerful program for joint linkage and\/or linkage disequilibrium analysis on mixtures of singletons and related individuals. Hum Hered. 2011;71(4):256\u201366.","journal-title":"Hum Hered"},{"issue":"D1","key":"1567_CR41","doi-asserted-by":"publisher","first-page":"D139","DOI":"10.1093\/nar\/gkw1064","volume":"45","author":"S Kumar","year":"2017","unstructured":"Kumar S, Ambrosini G, Bucher P. SNP2TFBS - a database of regulatory SNPs affecting predicted transcription factor binding site affinity. Nucleic Acids Res. 2017;45(D1):D139\u201344.","journal-title":"Nucleic Acids Res"},{"key":"1567_CR42","doi-asserted-by":"crossref","unstructured":"Xu Z, Taylor JA. SNPinfo: Integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Research, 2009. 37(SUPPL. 2).","DOI":"10.1093\/nar\/gkp290"},{"issue":"1","key":"1567_CR43","first-page":"1","volume":"2012 13","author":"C Liu","year":"2012","unstructured":"Liu C, et al. MirSNP, a database of polymorphisms altering miRNA target sites, identifies miRNA-related SNPs in GWAS SNPs and eQTLs. BMC Genomics. 2012;2012 13(1):1\u201310.","journal-title":"BMC Genomics"},{"issue":"9","key":"1567_CR44","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1101\/gr.137323.112","volume":"22","author":"AP Boyle","year":"2012","unstructured":"Boyle AP, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22(9):1790\u20137.","journal-title":"Genome Res"},{"issue":"4","key":"1567_CR45","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13353-013-0163-z","volume":"54","author":"M Switonski","year":"2013","unstructured":"Switonski M, Mankowska M, Salamon S. Family of melanocortin receptor (MCR) genes in mammals-mutations, polymorphisms and phenotypic effects. J Appl Genet. 2013;54(4):461\u201372.","journal-title":"J Appl Genet"},{"issue":"1","key":"1567_CR46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/YPG.0b013e32834133d2","volume":"21","author":"GS Wu","year":"2010","unstructured":"Wu GS, et al. Sequence polymorphisms of MC1R gene and their association with depression and antidepressant response. Psychiatr Genet. 2010;21(1):14\u20138.","journal-title":"Psychiatr Genet"},{"issue":"1","key":"1567_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/ijo.2014.79","volume":"39","author":"Z Yilmaz","year":"2015","unstructured":"Yilmaz Z, et al. Association between MC4R rs17782313 polymorphism and overeating behaviors. Int J Obes. 2015;39(1):114\u201320.","journal-title":"Int J Obes"},{"key":"1567_CR48","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jad.2018.09.003","volume":"243","author":"JT Heinzman","year":"2019","unstructured":"Heinzman JT, et al. GWAS and systems biology analysis of depressive symptoms among smokers from the COPDGene cohort. J Affect Disord. 2019;243:16\u201322.","journal-title":"J Affect Disord"},{"issue":"10","key":"1567_CR49","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/BF03401705","volume":"3","author":"YC Chagnon","year":"1997","unstructured":"Chagnon YC, et al. Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity-related phenotypes in the Quebec Family Study. Mol Med. 1997;3(10):663\u201373.","journal-title":"Mol Med"},{"key":"1567_CR50","doi-asserted-by":"crossref","unstructured":"Wang N et al. PDX1 and MC4R genetic polymorphisms are associated with type 2 diabetes mellitus risk in the Chinese Han population. BMC Med Genom, 2021;14(1).","DOI":"10.1186\/s12920-021-01037-3"},{"issue":"1","key":"1567_CR51","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12881-019-0876-x","volume":"20","author":"AA Batarfi","year":"2019","unstructured":"Batarfi AA, et al. MC4R variants rs12970134 and rs17782313 are associated with obese polycystic ovary syndrome patients in the western region of Saudi Arabia. BMC Med Genet. 2019;20(1):144.","journal-title":"BMC Med Genet"},{"key":"1567_CR52","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/TACG.S200341","volume":"12","author":"MJ Khan","year":"2019","unstructured":"Khan MJ, Ullah A, Basit S. Genetic basis of polycystic ovary syndrome (PCOS): current perspectives. Appl Clin Genet. 2019;12:249\u201360.","journal-title":"Appl Clin Genet"},{"issue":"7","key":"1567_CR53","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1007\/s43032-022-01149-w","volume":"30","author":"WY Almawi","year":"2023","unstructured":"Almawi WY, et al. Differential Association of FTO Gene variants and haplotypes with the susceptibility to polycystic ovary syndrome according to obesity in women with PCOS. Reprod Sci. 2023;30(7):2166\u201376.","journal-title":"Reprod Sci"},{"key":"1567_CR54","doi-asserted-by":"publisher","first-page":"147796","DOI":"10.1016\/j.gene.2023.147796","volume":"888","author":"P Sharma","year":"2023","unstructured":"Sharma P, et al. Genetic variants of metabolism and inflammatory pathways, and PCOS risk -systematic review, meta-analysis, and in-silico analysis. Gene. 2023;888:147796.","journal-title":"Gene"},{"issue":"4","key":"1567_CR55","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/cphy.c140006","volume":"4","author":"A Turcu","year":"2014","unstructured":"Turcu A, et al. Adrenal androgens and androgen precursors-definition, synthesis, regulation and physiologic actions. Compr Physiol. 2014;4(4):1369\u201381.","journal-title":"Compr Physiol"},{"issue":"1","key":"1567_CR56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/09513590.2016.1236078","volume":"33","author":"F Fruzzetti","year":"2017","unstructured":"Fruzzetti F, et al. Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2017;33(1):39\u201342.","journal-title":"Gynecol Endocrinol"},{"key":"1567_CR57","doi-asserted-by":"publisher","first-page":"105684","DOI":"10.1016\/j.jsbmb.2020.105684","volume":"200","author":"S Parween","year":"2020","unstructured":"Parween S, Rihs S, Fl\u00fcck CE. Metformin inhibits the activation of melanocortin receptors 2 and 3 in vitro: a possible mechanism for its anti-androgenic and weight balancing effects in vivo? J Steroid Biochem Mol Biol. 2020;200:105684.","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01567-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-024-01567-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01567-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T10:45:42Z","timestamp":1733395542000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-024-01567-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1567"],"URL":"https:\/\/doi.org\/10.1186\/s13048-024-01567-1","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"21 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}